Ann Arbor’s capacity to handle aggressive growth has been questioned over the past couple years as the city has charted a course for greater housing density. City officials now have more answers, which were Monday night,

Capital expenditure growth is a key indicator of how aggressively a company is investing in its future, whether through new infrastructure, equipment, technology, or capacity expansion. The following list ranks U.

Find growth stocks with high return potential and market outperformance. Analyze market trends and competitive advantages for smart investment decisions.

In a volatile market, investors can put themselves on the right path by focusing on companies with durable competitive advantages.

Vertiv Holdings is positioned as a digital infrastructure leader, serving AI data center customers. Read why VRT stock is a Buy.

Mega-cap tech firms have led returns for years, but with valuations stretched, some strategists favor a move into value. Growth stocks have posted outsize returns for years, but a changing economic outlook and elevated valuations could limit future gains.

Now, it’s worth noting Stock Advisor’s total average return is 983 % — a market-crushing outperformance compared to 200% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

Thrivent Large Cap Growth Fund underperformed the Russell 1000 Growth Index for 1Q26 by -0.74%. The Fund was down -10.52%, and the benchmark was down -9.78%. Read more here.

Trading down more than 30% from its highs, Shopify (NASDAQ: SHOP) has been caught up in investors' worries about software and consumer stocks. However, this is a fast-growing comp

Explore how export-led growth drives industrial development, its history, and key examples. Learn why countries may need to adopt new economic strategies.

Canopy Growth (NASDAQ: CGC) has been rallying lately, as excitement has been growing in the marijuana industry. The U.S. government recently announced it rescheduled medical marijuana from a Schedule I substance to Schedule III,